Gene · 6554
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Are International Units of Anti-HBs Antibodies Always Indicative of Hepatitis B Virus Neutralizing Activity? | Vaccines (Basel) | 2023 | 37112703 | PubTator, text mining | PubMed |
| Emerging Roles of Gut Microbial Modulation of Bile Acid Composition in the Etiology of Cardiovascular Diseases. | Nutrients | 2023 | 37111068 | PubTator, text mining | PubMed |
| HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis. | Int J Mol Sci | 2023 | 37108816 | PubTator, text mining | PubMed |
| Overcoming Biological Barriers: Importance of Membrane Transporters in Homeostasis, Disease and Disease Treatment. | Int J Mol Sci | 2023 | 37108379 | PubTator, text mining | PubMed |
| Hepatitis Delta Virus Antigens Trigger Oxidative Stress, Activate Antioxidant Nrf2/ARE Pathway, and Induce Unfolded Protein Response. | Antioxidants (Basel) | 2023 | 37107349 | PubTator, text mining | PubMed |
| Interactions of Na+/taurocholate cotransporting polypeptide with host cellular proteins upon hepatitis B and D virus infection: novel potential targets for antiviral therapy. | Biol Chem | 2023 | 37103224 | PubTator, text mining | PubMed |
| A human iPSC-derived hepatocyte screen identifies compounds that inhibit production of Apolipoprotein B. | Commun Biol | 2023 | 37095219 | PubTator, text mining | PubMed |
| Evaluation of the drug-drug interaction potential of the novel hepatitis B and D virus entry inhibitor bulevirtide at OATP1B in healthy volunteers. | Front Pharmacol | 2023 | 37089922 | PubTator, text mining | PubMed |
| In vitro cell culture models to study hepatitis B and D virus infection. | Front Microbiol | 2023 | 37089540 | PubTator, text mining | PubMed |
| Gut microbiome therapeutic modulation to alleviate drug-induced hepatic damage in COVID-19 patients. | World J Gastroenterol | 2023 | 37077515 | PubTator, text mining | PubMed |
| RIPK3 promoter hypermethylation in hepatocytes protects from bile acid-induced inflammation and necroptosis. | Cell Death Dis | 2023 | 37072399 | PubTator, text mining | PubMed |
| Mechanistic Middle-Out Physiologically Based Toxicokinetic Modeling of Transporter-Dependent Disposition of Perfluorooctanoic Acid in Humans. | Environ Sci Technol | 2023 | 37072124 | PubTator, text mining | PubMed |
| Near-infrared fluorescence imaging of hepatocellular carcinoma cells regulated by β-catenin signaling pathway. | Front Oncol | 2023 | 37064109 | PubTator, text mining | PubMed |
| The specific core fucose-binding lectin Pholiota squarrosa lectin (PhoSL) inhibits hepatitis B virus infection in vitro. | Sci Rep | 2023 | 37061516 | PubTator, text mining | PubMed |
| FXR and NASH: an avenue for tissue-specific regulation. | Hepatol Commun | 2023 | 37058105 | PubTator, text mining | PubMed |
| Farnesoid X receptor alpha ligands inhibit HDV in vitro replication and virion infectivity. | Hepatol Commun | 2023 | 37058078 | PubTator, text mining | PubMed |
| Hepatitis B Virus Targets Lipid Transport Pathways to Infect Hepatocytes. | Cell Mol Gastroenterol Hepatol | 2023 | 37054914 | PubTator, text mining | PubMed |
| In Silico Studies of the Impact of Rotational Errors on Translation Shifts and Dose Distribution in Image-Guided Radiotherapy. | Technol Cancer Res Treat | 2023 | 37050884 | PubTator, text mining | PubMed |
| Molecular Idiosyncratic Toxicology of Drugs in the Human Liver Compared with Animals: Basic Considerations. | Int J Mol Sci | 2023 | 37047633 | PubTator, text mining | PubMed |
| An Updated Overview of the Role of CYP450 during Xenobiotic Metabolization in Regulating the Acute Myeloid Leukemia Microenvironment. | Int J Mol Sci | 2023 | 37047003 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6554/papers?page=23